The initial reporter received questionable elecsys ft3 iii results for one patient tested on a cobas 8000 e 801 module.The e 801 module serial number was requested but was not provided.The customer reported the results to the patient's physician, and the physician asked for a re-measurement of the sample.The customer performed additional testing on an abbott architect.Also, the sample was submitted for an investigation and was tested on a cobas 8000 e 801 module and a cobas e 411 immunoassay analyzer.Refer to the attachment on the medwatch for all patient data.
|
The customer's calibration, qc, and sample pre-analytic data were requested but not provided.The patient's sample was provided for an investigation.The investigation confirmed the customer's thyroid results.Upon further investigation of the patient sample, an interferent against a component of the reagent was confirmed, streptavidin.This interference is covered in product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.Updated medwatch field: d4.
|